Ro Plus CHOEP as First Line Treatment Before HSCT in Young Patients With Nodal Peripheral T-cell Lymphomas

NCT02223208 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

89

Enrollment

OTHER

Sponsor class

Conditions

Peripheral T-cell Lymphomas (PTCL)
PTCL-NOS
Angioimmunoblastic T-cell Lymphoma (AITL)
ALK- Anaplastic Large Cell Lymphoma (ALCL)
Nodal Peripheral T-Cell Lymphoma of T Follicular Helper Cell Origin

Interventions

DRUG: Ro-CHOEP-21 (PHASE I)
DRUG: Ro-CHOEP-21 (PHASE II)

Sponsor

Fondazione Italiana Linfomi - ETS